You just read:

Forge Therapeutics Wins Powered by CARB-X Research Award of $8.8M to Accelerate Development of its LpxC Antibiotic to Kill the World's Deadliest 'Superbugs'

News provided by

Forge Therapeutics, Inc.

Mar 30, 2017, 11:16 ET